David Moore

2.7k total citations
29 papers, 748 citations indexed

About

David Moore is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, David Moore has authored 29 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Pharmacology and 9 papers in Genetics. Recurrent topics in David Moore's work include Pharmacogenetics and Drug Metabolism (5 papers), Estrogen and related hormone effects (5 papers) and Genomics and Rare Diseases (3 papers). David Moore is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Estrogen and related hormone effects (5 papers) and Genomics and Rare Diseases (3 papers). David Moore collaborates with scholars based in United Kingdom, United States and Switzerland. David Moore's co-authors include Ian Kimber, George M. Orphanides, Fei-Ling Lim, Jonathan G. Moggs, Ruth Stuckey, John Ashby, H. Tinwell, Wafaa El-Sankary, G. Gordon Gibson and Nick Plant and has published in prestigious journals such as Nature Communications, Environmental Health Perspectives and Bulletin of the American Meteorological Society.

In The Last Decade

David Moore

27 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Moore United Kingdom 15 313 177 166 116 70 29 748
Elisabetta De Marinis Italy 15 753 2.4× 122 0.7× 204 1.2× 183 1.6× 34 0.5× 27 1.3k
Monique Diry France 14 411 1.3× 171 1.0× 90 0.5× 123 1.1× 155 2.2× 17 837
E. Solheim Norway 12 181 0.6× 204 1.2× 320 1.9× 186 1.6× 27 0.4× 17 776
E Coëzy France 11 262 0.8× 88 0.5× 308 1.9× 88 0.8× 34 0.5× 21 606
Peter Christmas United States 17 657 2.1× 185 1.0× 83 0.5× 114 1.0× 20 0.3× 19 1.3k
Ivaylo Stoilov United States 18 670 2.1× 374 2.1× 292 1.8× 142 1.2× 62 0.9× 42 1.8k
D. Zhou United States 12 312 1.0× 90 0.5× 456 2.7× 142 1.2× 25 0.4× 16 638
Karen E. Swales United Kingdom 15 418 1.3× 151 0.9× 121 0.7× 310 2.7× 11 0.2× 29 919
Masaaki Kagimoto United States 13 566 1.8× 328 1.9× 228 1.4× 103 0.9× 20 0.3× 24 963
Zhengwen Jiang China 14 308 1.0× 141 0.8× 143 0.9× 90 0.8× 23 0.3× 30 685

Countries citing papers authored by David Moore

Since Specialization
Citations

This map shows the geographic impact of David Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Moore more than expected).

Fields of papers citing papers by David Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Moore. The network helps show where David Moore may publish in the future.

Co-authorship network of co-authors of David Moore

This figure shows the co-authorship network connecting the top 25 collaborators of David Moore. A scholar is included among the top collaborators of David Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Moore. David Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Linden, Dermot, Melanie L. Bailey, J. Michael Conlon, et al.. (2025). Effects of Hyperoxia on Pulmonary Inflammation and organ injury in a human in vivo model (HIPI): study protocol of a randomised, double-blind, placebo-controlled trial. BMJ Open Respiratory Research. 12(1). e002393–e002393. 1 indexed citations
2.
Abbott, Michael, Mandy Ryan, Rodolfo Hernández, et al.. (2024). Should Scotland provide genome-wide sequencing for the diagnosis of rare developmental disorders? A cost-effectiveness analysis. The European Journal of Health Economics. 26(3). 503–512.
3.
Khan, Tahir Naeem, Goutham Atla, David Parry, et al.. (2023). Regulatory de novo mutations underlying intellectual disability. Life Science Alliance. 6(5). e202201843–e202201843. 3 indexed citations
4.
Hodgson, Joshua, Lı́dia Ruiz, Jamie McDonald, et al.. (2021). Homozygous GDF2 nonsense mutations result in a loss of circulating BMP9 and BMP10 and are associated with either PAH or an “HHT‐like” syndrome in children. Molecular Genetics & Genomic Medicine. 9(12). e1685–e1685. 28 indexed citations
5.
Thormann, Anja, Mihail Halachev, William McLaren, et al.. (2019). Flexible and scalable diagnostic filtering of genomic variants using G2P with Ensembl VEP. Nature Communications. 10(1). 2373–2373. 53 indexed citations
6.
Nethisinghe, Suran, Sally Pemble, Mary G. Sweeney, et al.. (2018). PolyQ Tract Toxicity in SCA1 is Length Dependent in the Absence of CAG Repeat Interruption. Frontiers in Cellular Neuroscience. 12. 200–200. 16 indexed citations
7.
Kharbanda, Mira, Stephen Tennant, David Moore, et al.. (2017). Long QT syndrome and left ventricular noncompaction in 4 family members across 2 generations with KCNQ1 mutation. European Journal of Medical Genetics. 60(5). 233–238. 8 indexed citations
8.
Cleary, Elaine, Suvankar Pal, David Moore, et al.. (2016). Improved PCR based methods for detecting C9orf72 hexanucleotide repeat expansions. Molecular and Cellular Probes. 30(4). 218–224. 33 indexed citations
9.
Moore, David, et al.. (2015). Whole body vibration therapy: a novel potential treatment for type 2 diabetes mellitus. SpringerPlus. 4(1). 578–578. 15 indexed citations
10.
Wen, Bo & David Moore. (2011). Bioactivation of Glafenine by Human Liver Microsomes and Peroxidases: Identification of Electrophilic Iminoquinone Species and GSH Conjugates. Drug Metabolism and Disposition. 39(9). 1511–1521. 10 indexed citations
11.
Proukakis, Christos, David Moore, Robyn Labrum, Nicholas Wood, & Henry Houlden. (2011). Detection of novel mutations and review of published data suggests that hereditary spastic paraplegia caused by spastin (SPAST) mutations is found more often in males. Journal of the Neurological Sciences. 306(1-2). 62–65. 23 indexed citations
12.
Moggs, Jonathan G., Fei-Ling Lim, David Moore, et al.. (2005). Anti-proliferative effect of estrogen in breast cancer cells that re-express ERα is mediated by aberrant regulation of cell cycle genes. Journal of Molecular Endocrinology. 34(2). 535–551. 77 indexed citations
13.
Moggs, Jonathan G., John Ashby, H. Tinwell, et al.. (2004). The Need to Decide If All Estrogens Are Intrinsically Similar. Environmental Health Perspectives. 112(11). 1137–1142. 55 indexed citations
14.
Moggs, Jonathan G., H. Tinwell, Tracey D. Spurway, et al.. (2004). Phenotypic Anchoring of Gene Expression Changes during Estrogen-Induced Uterine Growth. Environmental Health Perspectives. 112(9). 1589–1606. 68 indexed citations
15.
Moggs, Jonathan G., H. Tinwell, Tracey D. Spurway, et al.. (2004). Phenotypic Anchoring of Gene Expression Changes during Estrogen-Induced Uterine Growth. Environmental Health Perspectives. 112(16). 1589–1606. 87 indexed citations
16.
17.
Moore, David, et al.. (1993). High-performance liquid chromatographic assay for two rifamycin-derived hypocholesterolemic agents in liver and biological fluids. Journal of Chromatography B Biomedical Sciences and Applications. 612(2). 310–314. 6 indexed citations
18.
Chapman, Dennis E., David Moore, Deborah C. Melder, Alan P. Breau, & Garth Powis. (1989). Isolation, identification and biological activity of a phyllanthoside metabolite produced in vitro by mouse plasma. Cancer Chemotherapy and Pharmacology. 25(3). 184–188. 2 indexed citations
19.
Moore, David, et al.. (1989). Model systems for detecting the hepatic toxicity of pyrrolizidine alkaloids and pyrrolizidine alkaloid N-oxides. Toxicology and Applied Pharmacology. 101(2). 271–284. 4 indexed citations
20.
Brodfuehrer, Joanne, et al.. (1988). In vitro cytotoxicity of pyrazine-2-diazohydroxide: specificity for hypoxic cells and effects of microsomal coincubation. Investigational New Drugs. 6(1). 3–9. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabetta De Marinis Breakdown of academic impact, for papers by Monique Diry Breakdown of academic impact, for papers by E. Solheim Breakdown of academic impact, for papers by E Coëzy Breakdown of academic impact, for papers by Peter Christmas Breakdown of academic impact, for papers by Ivaylo Stoilov Breakdown of academic impact, for papers by D. Zhou Breakdown of academic impact, for papers by Karen E. Swales Breakdown of academic impact, for papers by Masaaki Kagimoto Breakdown of academic impact, for papers by Zhengwen Jiang
Rankless by CCL
2026